Table 1.
Baseline | Follow-up | p-valuea | |
---|---|---|---|
Age, years | 8.6(1.7) | 16.3 (2.2) | <0.001 |
Tanner stage, score | --- | 4.1 (0.8) | --- |
Wheezing, % | 9.6% | 14% | 0.068 |
Chronic Cough, % | 5.8% | 5.0% | 0.671 |
Cough with exercise, % | 9.6% | 8.3% | 0.494 |
Allergies, % | 61.8% | 58.3% | 0.528 |
Enlarged tonsils, % | 33.8% | --- | --- |
Tonsils inflammation, % | 1.8% | --- | --- |
Cervical adenopathy, % | 27.4% | --- | --- |
Height, cm | 133.9(10.9) | 168.1 (9.8) | <0.001 |
Weight, kg | 29.4 (6.4) | 59.2(10.0) | <0.001 |
zBMI, z-score | −0.6 (0.8) | −0.1 (0.8) | 0.028 |
BMI%, percentile | 44.9 (22.5) | 48.4(24.1) | <0.001 |
Neck circumference, cm | 27.9 (4.2) | 34.2(5.1) | <0.001 |
Waist circumference, cm | 59.9(5.1) | 73.2(7.1) | <0.001 |
Hips circumference, cm | 68.7 (8.7) | 84.1 (9.3) | <0.001 |
Gynoid/whole ratio, % | --- | 18.6 (2.5) | --- |
Android/whole ratio, % | --- | 5.5(1.0) | --- |
Subcutaneous tissue, cm2 | --- | 139.7(85.9) | --- |
Visceral tissue, cm2 | --- | 38.4(15.0) | --- |
CRP, mg/L | --- | 0.7 (0.6) | --- |
IL-6, pg/mL | --- | 1.0(0.9) | --- |
TNF-α, pg/mL | --- | 1.8(1.2) | --- |
Leptin, ng/mL | --- | 8.4 (8.5) | --- |
Adiponectin, μg/mL | --- | 8.4 (4.9) | --- |
Total sleep time, min | 461.1 (44.3) | 447.8 (49.0) | <0.001 |
Stage N1,% | 3.3 (2.7) | 0.9(1.0) | <0.001 |
Stage 2, % | 46.3 (10.8) | 53.2 (10.2) | <0.001 |
Stage 3, % | 30.1 (10.2) | 27.2 (9.5) | <0.001 |
Stage R, % | 20.4 (5.2) | 18.6(4.7) | <0.001 |
PLMI, events/hour | 0.8 (4.0) | 4.5 (6.8) | <0.001 |
AHI, events/hour | 0.7 (0.9) | 2.3 (6.3) | <0.001 |
Data are mean (standard deviation) for continuous variable and percentage for categorical variables. b Bold p-values indicate statistical significance at p ≤ 0.05. Participants identified their race/ethnicity from one of six options and “ethnic/race minority status” was defined as “nonwhite/Caucasian and/or Hispanic”. AHI = apnea hypopnea index. BMI = body mass index. CRP= C-reactive protein. IL-6 = interleukin-6. PLMI = periodic limb movement index. TNF-α = tumor necrosis factor alpha.